Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2
Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J. Greaney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12

Showing 12 citing articles:

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 13
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 5
SARS-CoV-2 Fusion Peptide-Directed Antibodies Elicited by Natural Infection Mediate Broad Sarbecovirus Neutralization
Alex Roederer, Yi Cao, Chia Jung Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Functional and antigenic landscape of the Nipah virus receptor binding protein
Brendan B. Larsen, Teagan McMahon, Jack T. Brown, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
Ching‐Wen Hou, Stacy Williams, Veronica Boyle, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 61-61
Open Access
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Barbara Mühlemann, Samuel Wilks, Lauren Baracco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection
Jamie Guenthoer, Michelle M. Lilly, Tyler N. Starr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Jamie Guenthoer, Meghan Garrett, Michelle M. Lilly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses
Felicitas Ruiz, William Foreman, Michelle M. Lilly, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012650-e1012650
Open Access
Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies
Brady T. Hickerson, A. M. Khalenkov, Tao Xie, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1698-1698
Open Access | Times Cited: 1
Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern
Adonis A. Rubio, Viren A. Baharani, Bernadeta Dadonaite, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top